Psychedelics May Trigger Quantum Brain Processes

A peer-reviewed article authored by NetraMark suggests psychedelics may do more than alter brain chemistry, potentially involving quantum-level processes inside the brain. The findings add a new dimension to understanding how psychedelic compounds produce their effects. The publication strengthens NetraMark's argument for using biomarker-guided enrichment, individualized response modeling, and explainable AI in psychedelic clinical trial design. The Toronto-based AI company focuses on transforming clinical trials through precision analytics.